Eruzun, Hasan. “Sclerosing Cholangitis Associated With dabrafenib–trametinib Therapy: BRAF/MEK Inhibitors Should Be Considered”. Journal of Gastrointestinal and Liver Diseases 35, no. 1 (March 27, 2026): 136–137. Accessed July 18, 2026. https://www.jgld.ro/jgld/index.php/jgld/article/view/6698.